Frequency and causes for exclusion from randomization of healthy volunteers screened for a phase 1 study in India

National Medical Journal of India

Volumn 25, Issue 1, 2012, Pages 18-20

  Gogtay, N J ^a,b   Thatte, U M ^a,b   Kulkarni, P S ^a,b  

^a KEM HOSPITAL   (India)

^b Serum Institute of India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL STUDY; CONTROLLED STUDY; DEVELOPING COUNTRY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ESSENTIAL HYPERTENSION; FEMALE; FEVER; GOITER; HEPATOSPLENOMEGALY; HUMAN; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); REFUSAL TO PARTICIPATE; RESEARCH SUBJECT; SCREENING TEST; TREATMENT REFUSAL; VOLUNTEER;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; PATIENT SELECTION; RABIES; RABIES VIRUS; VOLUNTARY WORKERS; YOUNG ADULT;

EID: 84860998158     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Joubert P, Rivera-Calimlim L, Lasagna L. The normal volunteer in clinical investigation: How rigid should selection criteria be? [Commentary] Clin Pharmacol Ther 1975;17:253-257.
2. Woodward WE. Informed consent of volunteers: A direct measurement of comprehension and retention of information. Clin Res 1979;27:248-252.
3. Sibille M, Vital Durand D. Laboratory screening method for selection of healthy volunteers. Eur J Clin Pharmacol 1990;39:475-479.
4. Sibille M, Deigat N, Durieu I, Guillaumont M, Morel D, Bienvenu J, et al. Laboratory data in healthy volunteers: Reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials. Eur J Clin Pharmacol 1999;55:13-19.
5. Wolen RL, Rubin A, Rodda BE, Ridolfo AS, Gruber CM Jr. Problems associated with bioavailability and dosage regiment studies in man. J Pharmacokinet Biopharm 1974;2:365-377.
6. Joubert P, Pannall P. The selection of healthy volunteers for clinical investigation: The case for volunteer pools. Curr Med Res Opin 1976;4:192-196.
7. Thompson WL, Brunelle RL, Enas GG, Simpson PJ. Routine laboratory tests in clinical trials: interpretation of results. J Clin Res Drug Devel 1987;1:95-119.
8. Schoen I, Brooks SH. Judgment based on 95 per cent confidence limits: A statistical dilemma involving multitest screening and proficiency testing of multiple specimens. Am J Clin Pathol 1970;53:190-193.
9. Almeida L, Azevedo B, Nunes T, Vaz-da-Silva M, Soares-da-Silva P. Why healthy subjects volunteer for phase I studies and how they perceive their participation? Eur J Clin Pharmacol 2007;63:1085-1094.
10. Paul VK, Sachdev HS, Mavalankar D, Ramachandran P, Sankar MJ, Bhandari N, et al. Reproductive health, and child health and nutrition in India: Meeting the challenge. Lancet 2011;377:332-349.
11. Tishler CL, Bartholomae S. Repeat participation among normal healthy research volunteers: Professional guinea pigs in clinical trials? Perspect Biol Med 2003;46: 508-520.
12. Strengthening clinical research in India [Commentary]. Lancet 2007;369:1233.